Published: February 14, 2021
Oxford University announced Friday it started testing its coronavirus vaccine in children as young as six in a move that expands coronavirus vaccine trials to the youngest age group yet.
Published: February 08, 2021
LONDON - South Africa will suspend use of the coronavirus vaccine being developed by Oxford University and AstraZeneca after researchers found that it provided "minimal protection" against mild to moderate coronavirus infections caused by the new variant first detected in that country.
Published: February 04, 2021
LONDON - The developers of the Oxford-AstraZeneca coronavirus vaccine report that it may help keep people from spreading the virus, offering a hopeful but uncertain answer to one of the great remaining questions of the pandemic.
Published: December 30, 2020
LONDON - Britain on Wednesday became the first country to grant approval for a homegrown coronavirus vaccine from the University of Oxford and the British-Swedish pharmaceutical firm AstraZeneca, adding a second shot to the fight against a surging outbreak, driven here by a new, highly infectious variant of the virus.
Published: November 20, 2020
The large number of foreign tourists visiting each year includes a large group that has started to look at condominiums to buy, so they can have a place to stay when they visit Phuket.Some also sought additional rental income when they were not in residence.
Published: August 28, 2020
The much-awaited trial of COVID-19 vaccine developed by the University of Oxford started in India on Wednesday. Pune-based Serum Institute of India (SII) partnered with AstraZeneca to manufacture the COVID-19 vaccine candidate for India and low-and-middle income countries.
Published: August 25, 2020
The Public Health Ministry has asked the Budget Bureau to consider a Bt600-million project on production of Covid-19 vaccines with Oxford University and pharmaceutical companies in England, Minister Anutin Charnvirakul confirmed today (August 25).
Published: July 21, 2020
LONDON -- An Oxford University group and the British-Swedish pharmaceutical company AstraZeneca reported Monday that their coronavirus vaccine candidate, on which the U.S. and European governments have placed substantial bets, was shown in early-stage human trials to be safe and to stimulate an immune response.